DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $215,847 | +3.4% | 870 | 0.0% | 0.53% | +7.5% |
Q2 2023 | $208,800 | -4.8% | 870 | 0.0% | 0.49% | -17.0% |
Q1 2023 | $219,275 | -5.0% | 870 | 0.0% | 0.59% | -12.9% |
Q4 2022 | $230,915 | +2.6% | 870 | 0.0% | 0.68% | -9.6% |
Q3 2022 | $225,000 | +1.8% | 870 | 0.0% | 0.75% | +8.5% |
Q2 2022 | $221,000 | -13.3% | 870 | 0.0% | 0.69% | +11.6% |
Q1 2022 | $255,000 | -10.8% | 870 | 0.0% | 0.62% | -2.0% |
Q4 2021 | $286,000 | -14.6% | 870 | -20.9% | 0.64% | -4.5% |
Q3 2021 | $335,000 | +13.6% | 1,100 | 0.0% | 0.66% | +12.9% |
Q2 2021 | $295,000 | +19.0% | 1,100 | 0.0% | 0.59% | +7.9% |
Q1 2021 | $248,000 | -30.1% | 1,100 | -31.2% | 0.55% | -16.9% |
Q4 2020 | $355,000 | +2.9% | 1,600 | 0.0% | 0.66% | +15.1% |
Q3 2020 | $345,000 | +21.9% | 1,600 | 0.0% | 0.57% | +9.8% |
Q2 2020 | $283,000 | +28.1% | 1,600 | 0.0% | 0.52% | -0.2% |
Q1 2020 | $221,000 | -10.2% | 1,600 | 0.0% | 0.52% | +24.3% |
Q4 2019 | $246,000 | -6.8% | 1,600 | -20.0% | 0.42% | +19.0% |
Q1 2019 | $264,000 | – | 2,000 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |